Brought to you by 
Neurocrine Biosciences raises $34.2mm in IPO of 3.5mm shares.
13 Jul 1999
Executive Summary
Neurocrine Biosciences (therapeutics for disorders of the central nervous and immune systems) has completed an initial public offering of 3.5mm shares priced at $10.50 per share, raising a net of $34.18mm.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
-
Drug Discovery Tools
- Molecular Diversity
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neurocrine Biosciences raises $34.2mm in IPO of 3.5mm shares.
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice